GSK256073 acutely regulates NEFA levels via HCA2 agonism but does not achieve durable glycaemic control in type 2 diabetes. A randomised trial.
Eur J Pharmacol
; 755: 95-101, 2015 May 15.
Article
in En
| MEDLINE
| ID: mdl-25773496
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Xanthines
/
Receptors, G-Protein-Coupled
/
Diabetes Mellitus, Type 2
Type of study:
Clinical_trials
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur J Pharmacol
Year:
2015
Document type:
Article
Affiliation country:
United States
Country of publication:
Netherlands